Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies
Endo Calc icon

1.0.0 by febcrthy


Jul 16, 2022

About Endo Calc

App for endocrinologists.

Endo Calc is an app developed for the practicing endocrinologist by an endocrinologist. Many routine tasks that require complex calculations can be done using Endo Tools in a few clicks!

Features include:

1) Convert HbA1c to average blood glucose and fructosamine.

2) Convert steroids.

3) Thyroid nodule volume calculator

4) Thyroid cancer staging

5) Thyroxine dose calculator

6) Calcium corrected for albumin

7) Fractional excretion of calcium for familial benign hypocalcuric hypercalcemia

8) NAFLD fibrosis score

and several other calculators.

The information on this App is not a substitute for professional medical advice, diagnosis, or treatment. All content, including text, graphics, images, and information, contained on or available through this App is for general information purposes only. This app is intended for educational purposes only and is not intended to diagnose, treat or cure any disease based on the sole output of the app. Seek a doctor’s advice in addition to using this app and before making any medical decisions.

What's New in the Latest Version 1.0.0

Last updated on Jul 16, 2022

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request Endo Calc Update 1.0.0

Requires Android

4.1

Show More

Endo Calc Screenshots

Comment Loading...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.